A Life Science Accelerator

501 Ventures is a Life Science Accelerator Providing Turnkey Solutions for IP Based Technologies

501 Ventures is an umbrella organization providing investment opportunities in asset-based subsidiaries while providing capital efficiency of shared talent and overhead

The 501 Ventures Competitive Advantage

Track record of company and asset exits in the industry:

Leadership team has deep understanding of big pharma’s needs to drive efficiency

Proven track record managing small and lean start-ups:

Search team performs extensive due dilligence identifying high priority requirements needed to get assets to next inflection point.


Comprehensive in-house clinical development experts:

The majority of clinical development is done in house without use of CROs decreasing the time and financial resources needed.




Phase 1

Phase 2

Phase 3

Drug-Device Combination to Manage External Bleeding

Bio 751


Our team at 501 Ventures is comprised of entrepreneurs with executive leadership experience

  • The shared model allows human capital and overhead to be distributed across 2-4 programs providing subsidiaries experienced talent and infrastructure at a fraction of the cost
  • Capital raised in subsidiaries that have service arrangement with 501
  • The majority of clinical work is done “in house” with minimal use of third party vendors providing time and financial savings

    Meet Our Team

    Meg Powell, Pharm. D.

    Chief Executive Officer

    Hazar Granko, PhD

    Chief Development Officer

    Dave Brown

    Chief Strategy Officer

    Jennifer Woods

    VP Finance and Operations 

    Laura Malahias

    VP Clinical Operations

    Bushra Agha

    CMC Lead

    John Kapeghian

    Preclinical/Toxicology Lead

    George DeMuth

    Statistics Lead

    Bruce Wiggin

    Engineering Lead

    Bill Wargin

    Pharmacokinetics Lead


    Board of Advisors

    Moise A Khayrallah, PhD


    Emergo Therapeutics

    Paul Sekhri

    President and CEO

    eGenesis, Inc

    Sue Mahony, PhD MBA

    Board Director